FIELD: medicine; pharmacology.
SUBSTANCE: invention can be used for prevention of erosive and ulcer lesions of stomach caused by nonsteroid anti-inflammatory agents. Invention represents calcium pectate introduced orally in daily dose 0.025-0.5 g/kg of body weight within not less than 8 days prior to nonsteroid anti-inflammatory agents.
EFFECT: improved efficiency of ulcer prevention.
3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTING INJURY OF STOMACH MUCOSA CAUSED BY APPLICATION OF NON-STEROID ANTI-INFLAMMATORY MEDICATIONS | 2011 |
|
RU2455984C1 |
| METHOD FOR PREVENTION OF GASTRIC MUCOSAL DAMAGE CAUSED BY ADMINISTRATION OF NONSTEROID ANTI-INFLAMMATORY AGENTS | 2010 |
|
RU2449784C1 |
| PREPARATION, POSSESSING GASTROPROTECTIVE ACTIVITY | 2014 |
|
RU2536225C1 |
| MEANS WITH GASTROPROTECTIVE ACTIVITY | 2016 |
|
RU2629090C1 |
| METHOD FOR PREPARING AGENT POSSESSING ANTIULCEROGENIC ACTION | 2013 |
|
RU2533228C2 |
| METHOD FOR PREPARING ANTIULCER GASTRORETENTIVE AGENT | 2013 |
|
RU2531092C1 |
| METHOD FOR PREPARING DRUG POSSESSING ANTIULCEROGENIC, ANTISTRESS AND HEMOSTATIC ACTIVITIES | 2012 |
|
RU2495674C1 |
| METHOD OF OBTAINING MEANS OWNING GASTROSPARING, ANTI-INFLAMMATORY, ANTIOXIDANT ACTIVITY | 2018 |
|
RU2679310C1 |
| MEDICATION POSSESSING ANTI-HELICOBACTER ACTION | 2009 |
|
RU2416414C1 |
| METHOD FOR PREVENTING AND TREATING GASTRIC ULCER LESION CAUSED BY ADMINISTERING NONSTEROIDAL ANTIINFLAMMATORY AGENTS | 2013 |
|
RU2530615C1 |
